St. Louis-based Biotech startup, Unleash Immuno Oncolytics, announced today it has raised $3 million investment from publicly-traded Japanese-based Oncolys BioPharma to advance cancer therapies. Founded in 2015, Unleash Immuno Oncolytics develops oncolytic virus immunotherapy products to treat cancer. The company offers UIO-512, an oncolytic […]
0
3.4K Views